Halozyme Therapeutics, Inc.HALONASDAQ
Loading
EPS Diluted Over TimeContracting
Percentile Rank86
3Y CAGR+20.0%
5Y CAGR+22.3%
Year-over-Year Change
Diluted earnings per share
3Y CAGR
+20.0%/yr
Annual compound
5Y CAGR
+22.3%/yr
Consistent
Percentile
P86
Within normal range
vs 5Y Ago
2.7x
Strong expansion
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | 2.49 | -27.4% |
| 2024 | 3.43 | +63.3% |
| 2023 | 2.10 | +45.8% |
| 2022 | 1.44 | -47.4% |
| 2021 | 2.74 | +201.1% |
| 2020 | 0.91 | +282.0% |
| 2019 | -0.50 | +10.7% |
| 2018 | -0.56 | -224.4% |
| 2017 | 0.45 | +155.6% |
| 2016 | -0.81 | - |